Calycia Bioscience was awarded the People’s Choice Award at the 2026 Altitude Labs Demo Day. CaLycia is developing engineered macrophage therapies that hone in on solid tumors and alleviate immune suppression, unlocking a broader immune response against some of the hardest targets in oncology. BioUtah congratulates Daniel Greiner and the Calycia Bioscience team!
